Literature DB >> 15754028

Clinical significance of abnormal lipoprotein patterns in liver diseases.

Kinue Ooi1, Katsuya Shiraki, Yuko Sakurai, Yoshitska Morishita, Tsutomu Nobori.   

Abstract

We analyzed lipids in liver diseases by agarose gel electrophoresis, and differential staining and simultaneous analysis of the cholesterol (Chol) and triglyceride (TG) fractions. Liver diseases were classified into chronic hepatitis (CH), liver cirrhosis (LC), hepatocellular carcinoma (HCC), and metastatic liver cancer, and each fraction was compared among these diseases. Atypical patterns that were unclassifiable according to the WHO classification of hyperlipidemia phenotypes were classified, and their clinical importance was evaluated. With progression of the pathologic conditions of CH, LC, and HCC, the T-Chol level, each Chol fraction, and the TG fraction decreased while the LDL-TG fraction increased. Metastatic liver cancer showed a lower HDL-fraction level but higher levels of the other parameters than HCC. When the subjects were classified into survivors and patients who died, the HDL fraction level in HCC and metastatic liver cancer, and the LDL level in LC and metastatic liver cancer differed between survivors and patients who died. Phenotypes of hyperlipidemia also differed among diseases, and atypical patterns were frequently observed in patients who died. There were 6 atypical patterns, of which 4 (slow alpha HDL, abnormal LDL, Lp-X, and Lp-Y) were associated with liver diseases. Slow alpha HDL appeared during slight bile stagnation and was accompanied by increases in the apo E level and the HDL particle size. Abnormal LDL appeared with severe liver dysfunction; a TG peak appeared at the position of LDL, and the HDL and VLDL fractions were negligible. Lp-X was a Chol-rich band, occurring on the cathode side of LDL in the presence of marked bile stagnation such as that in obstructive jaundice, and was accompanied by appearance of abnormal LDL. Lp-Y was similar to Lp-X in terms of mobility and associated diseases but contained Chol and TG. Abnormal LDL, Lp-X, and Lp-Y were often observed in patients with poor outcomes. Lipid analysis in liver diseases by this method showed results reflecting the pathologic conditions and may be clinically useful.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754028

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  27 in total

1.  N-Acetyl-2-Aminofluorene (AAF) Processing in Adult Rat Hepatocytes in Primary Culture Occurs by High-Affinity Low-Velocity and Low-Affinity High-Velocity AAF Metabolite-Forming Systems.

Authors:  Katherine S Koch; Tom Moran; W Thomas Shier; Hyam L Leffert
Journal:  Toxicol Sci       Date:  2018-05-01       Impact factor: 4.849

Review 2.  Metabolism of high density lipoproteins in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Chang-Ping Wu
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

3.  Immunochemical composition of cryoglobulins generated in stroke.

Authors:  Levon Manukyan; Anna Boyajyan; Arsen Arakelyan; Violetta Ayvazyan; Elina Arakelova; Robert Sim; George Grigoryan
Journal:  J Clin Immunol       Date:  2008-11-04       Impact factor: 8.317

4.  Proteomic analysis for developing new biomarkers of hepatocellular carcinoma.

Authors:  Maria Pleguezuelo; Laura M Lopez-Sanchez; Antonio Rodriguez-Ariza; Jose L Montero; Javier Briceno; Ruben Ciria; Jordi Muntane; Manuel de la Mata
Journal:  World J Hepatol       Date:  2010-03-27

5.  Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.

Authors:  Jian-Min Wu; Nicholas J Skill; Mary A Maluccio
Journal:  HPB (Oxford)       Date:  2010-11       Impact factor: 3.647

Review 6.  Lipids changes in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Xiao-Ying Zhang; Chang-Ping Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

7.  Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma.

Authors:  Mario Uccello; Giulia Malaguarnera; Elisa M Pelligra; Antonio Biondi; Francesco Basile; Massimo Motta
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04

8.  The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins.

Authors:  Lech Chrostek; Lukasz Supronowicz; Anatol Panasiuk; Bogdan Cylwik; Ewa Gruszewska; Robert Flisiak
Journal:  Clin Exp Med       Date:  2014-11       Impact factor: 3.984

9.  Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.

Authors:  Jingting Jiang; Xiaoying Zhang; Changping Wu; Xihu Qin; Guanghua Luo; Haifeng Deng; Minyang Lu; Bin Xu; Min Li; Mei Ji; Ning Xu
Journal:  Lipids Health Dis       Date:  2008-07-24       Impact factor: 3.876

Review 10.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.